Related Experiment Video

Updated: Jul 1, 2025

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

8.2K

Managing hypercholesterolaemia

Adam J Nelson1,2,3, Stephen J Nicholls1,2,3

  • 1Royal Adelaide Hospital.

Australian Prescriber
|March 6, 2024
PubMed

Insights

Lowering low-density lipoprotein cholesterol (LDL-C) significantly reduces cardiovascular event risk. Effective management, including combination therapy, is crucial for patients with hypercholesterolaemia.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Hypercholesterolaemia is a prevalent condition managed by Australian clinicians.
  • Low-density lipoprotein cholesterol (LDL-C) is a key factor in atherosclerosis and cardiovascular disease (CVD) development.
  • A 1 mmol/L reduction in LDL-C correlates with a 21-25% decreased risk of atherosclerotic events, with benefits potentially increasing over time.

Purpose of the Study:

  • To emphasize the importance of LDL-C management in cardiovascular health.
  • To highlight the role of absolute cardiovascular risk assessment in guiding treatment intensity.
  • To underscore the potential need for combination drug therapy in managing LDL-C.

Main Methods:

  • Review of existing clinical data and evidence regarding hypercholesterolaemia management.
  • Analysis of the relationship between LDL-C reduction and cardiovascular event risk.
  • Discussion of risk stratification tools for patient management.

Main Results:

  • Significant reduction in atherosclerotic cardiovascular events with LDL-C lowering.
  • Evidence suggests cumulative benefits of LDL-C reduction over time.
  • Absolute cardiovascular risk assessment effectively identifies high-benefit patient groups.

Conclusions:

  • Lowering LDL-C is critical for preventing and managing cardiovascular disease.
  • Personalized treatment strategies based on absolute cardiovascular risk are essential.
  • Combination therapy may be necessary for optimal LDL-C control in hypercholesterolaemia.

Keywords:
LDL cholesterolPCSK9 inhibitorsezetimibehypercholesterolaemiastatins

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.4K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
544
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
735
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
163
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
88
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92